<DOC>
	<DOC>NCT00469131</DOC>
	<brief_summary>The aim of this study is to compare immunosuppression protocol of tacrolimus + MMF with that of tacrolimus + steroid for preventing recurrence of hepatitis C after living donor liver transplantation.</brief_summary>
	<brief_title>Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Recipient of living donor liver transplantation for HCVrelated cirrhosis ABO blood type incompatible transplant case Renal dysfunction (serum creatinine &gt;2.0 mg/dL) WBC &lt; 1,000/mm3 Hemoglobin &lt; 8 g/dL Platelet &lt;30,000 /mm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>liver transplantation,</keyword>
	<keyword>HCV recurrence,</keyword>
	<keyword>immunosuppression</keyword>
</DOC>